Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

October 16, 2023
Virginia Cancer Specialists » VCS Practice News » Clinical Trials and Research » VCS Practice News » Clinical Trials Search » Investigational Inhibitor of Active RAS Shows Clinical Promise – Alexander I. Spira, MD, PhD, FACP

Investigational Inhibitor of Active RAS Shows Clinical Promise –  The therapy uses a different mechanism than approved KRAS G12C inhibitors and targets multiple RAS mutations beyond KRAS G12C

 thumbnail of Targets23_Spira_RasON_FINAL

Alexander I Spira MD, PhD, FACP, FASCO Headshot

Alexander I Spira MD, PhD, FACP, FASCO

Medical Oncologist

Recent Posts

New OncoTalks Episode: Advancing Biomarker Testing in NSCLC - Dr. Alexander I. Spira, MD, PhD, FACP, FASCO
New OncoTalks Episode: Advancing Biomarker Testing in NSCLC - Dr. Alexander I. Spira, MD, PhD, FACP, FASCO
February 9, 2026
Read More
For the Third Consecutive Year, Virginia Cancer Specialists Named #1 Practice in Virginia for Cancer Care, and Ranked #1 Across All Medical Specialties
For the Third Consecutive Year, Virginia Cancer Specialists Named #1 Practice in Virginia for Cancer Care, and Ranked #1 Across All Medical Specialties
February 5, 2026
Read More
32 Virginia Cancer Specialists Physicians Named Among NorthernVirginia Magazine’s 2026 Top Doctors for Excellence in Personalized Cancer Care
32 Virginia Cancer Specialists Physicians Named Among NorthernVirginia Magazine’s 2026 Top Doctors for Excellence in Personalized Cancer Care
January 28, 2026
Read More
WEATHER ALERT: January 25 - 5:15 PM
WEATHER ALERT: January 25 - 5:15 PM
January 25, 2026
Read More
Bringing Advanced Cancer Care Closer to Home at Reston Hospital
Bringing Advanced Cancer Care Closer to Home at Reston Hospital
January 19, 2026
Read More

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More
Return to Top